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Epidermodysplasia verruciformis (EV) is a rare gen-
odermatosis associated with a high risk of skinFig. 1 (a) Hyperpigmented SK-like lesions on the boy’s face a
and trunk. (c) Successful treatment of SK-like lesions by cryosu
face, neck and trunk of the female. (e) PV-like lesions on th
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doi:10.1016/j.jdermsci.2007.01.002cancer. This condition is characterized by an abnor-
mal susceptibility to human papillomavirus geno-
types from the genus beta. The cutaneous lesions of
EV first appear in childhood and are highly poly-
morphic. Multiple squamous cell carcinomas (SCC)
of the skin develop subsequently on sun-exposednd forehead. (b) Brown, scaly PV-like macules on the neck
rgery. (d) Multiple brownish plaques and SK-like lesions on
e hands.
tology. Published by Elsevier Ireland Ltd. All rights reserved.
Letter to the Editor 215sites in about half of the patients. Benign cutaneous
lesions are associated with polymorphic lesions
such as pityriasis versicolor-like (PV-like) macules,
flat warts and red macules. EV is believed to be an
autosomal recessive disease (reviewed in ref. [1]).
Two susceptibility loci, EV1 and EV2, have been
mapped with EV1 containing the characterized
EVER1 and EVER2 genes [2].
In this report, we present a 22-year-old Turkish
male and his 45-year-old mother with extensive
seborrheic keratosis-like (SK-like) viral warts with
no family history of EV. Initial facial lesions devel-
oped aged 8 years and disseminated with time. PV-
like brown scaly macules resembling pityriasis
versicolor were observed on the trunk and neck
(Fig. 1b and d). The patients showed SK-like viral
warts characterized by dark brown or black pig-
mented proliferative lesions with hyperkeratotic
surfaces. Facial SK-like lesions were dark and pla-
que-like (Fig. 1a and d). All lesions disappeared
following liquid nitrogen cryosurgery (Fig. 1c).
Blood profile (son) including full blood count, ery-
throcyte sedimentation rate, C-reactive protein,
liver and renal function tests, serum lipid and
cholesterol level, levels of immunoglobulins, com-
plement components and circulating immune com-
plexes were normal. The patient showed no
decrease in the number of CD8+ T-cells as
described previously for EV [10]. The patient
was HIV-negative.
Skin biopsies were taken from a SK-like wart and
histopathologic evaluation of a warty lesion revealed
hyperkeratosis and hypergranulosis with vacuolation
and koiliocytes consistent with HPV infection. The
lesion showed mild to moderate dysplasia in theFig. 2 Histology of SK-like viral wart from the boy (a and b) an
50-fold magnification; (b and d) 200-fold magnification.epidermis (Fig. 2). The dermatopathological findings
were pathognomic for EV.
HPV DNA analysis was performed on a formalin-
fixed, paraffin-embedded hyperkeratotic lesion
from the face. The sample was tested positive for
oncogenic HPV type 8 using a multiple nested
degenerated PCR method with the capacity to
detect a broad spectrum of cutaneous, alpha-
and beta-HPV types [3]. No other HPV types were
detected.
Genetic analysis of the genes EVER1 and EVER2,
two known genes to be associated with this
disease, did not detect any loss of function muta-
tions by sequencing the coding exons from geno-
mic DNA with previously described primers [2]. We
found only a non-synonymous single nucleotide
polymorphism in the intron between exon 10
and exon 11 (cacctgccc[c/g]ctggggaggcag) of
EVER1.
This phenotype of EV, dominated by SK-like
lesions, has previously been reported in a subset
of African EV patients [4—6]. This is the first report
of this EV phenotype in a Caucasian family. The
diagnosis of EV is supported by the characteristic
histology and the presence of the EV-associated
HPV8. Both patients showed PV-like scaly macules
in addition to the clinically dominant SK-like warts.
To our knowledge, EVER mutations have previously
been described in few reports [2,7—9], with only
one publication reporting the lack of EVER mutation
[10]. Our analysis shows also lack of EVER1 and
EVER2 mutations and represents a distinct clinical
and genetic variant of EV underlining the probable
involvement of other genetic loci in the develop-
ment of this disease.d his mother (c and d) showing typical EV changes. (a and c)
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